GlassScriptPhysician profile
Allison K Wick
NPI 1497772461
$504.24
in general payments reported to CMS, 2019-2025
11 companies · $84.54 in 2025
The $84.54 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.46 · 2022: $118 · 2023: $191 · 2024: $77.91 · 2025: $84.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $104.57 | 2022-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $74.76 | 2021-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $59.81 | 2023-2025 | |
| Lilly USA, LLC | $53.59 | 2022-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.38 | 2023-2025 | Jardiance, Tradjenta |
| Abbvie INC. | $51.45 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $30.88 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $24.44 | 2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $22.63 | 2022 | |
| Amgen INC. | $15.45 | 2024 | Repatha, Otezla |
| Idorsia Pharmaceuticals US INC | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.